1. Jensterle, Mojca, et al. “Efficacy of GLP-1 RA Approved for Weight Management in Patients with or without Diabetes: A Narrative Review.” Advances in Therapy, vol. 39, no. 6, 3 May 2022, pp. 2452–2467, https://doi.org/10.1007/s12325-022-02153-x.
2. Wharton, Sean, et al. “Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.” The New England Journal of Medicine, vol. 389, no. 10, 23 June 2023, https://doi.org/10.1056/nejmoa2302392.
3. “Considering GLP-1 Medications? What They Are and Why Lifestyle Change Is Key to Sustained Weight Loss.” Mayo Clinic Diet, diet.mayoclinic.org/us/blog/2023/considering-glp-1-medications-what-they-are-and-why-lifestyle-change-is-key-to-sustained-weight-loss/.
4. “GLP-1 Drugs for Weight Loss: How Do They Work, Exactly?” Www.medicalnewstoday.com, 18 Mar. 2024, www.medicalnewstoday.com/articles/how-semaglutide-and-similar-drugs-act-on-the-brain-and-body-to-reduce-appetite. Accessed 19 Mar. 2024.
5. Müller, T.D., et al. “Glucagon-like Peptide 1 (GLP-1).” Molecular Metabolism, vol. 30, Dec. 2019, pp. 72–130, www.ncbi.nlm.nih.gov/pmc/articles/PMC6812410/, https://doi.org/10.1016/j.molmet.2019.09.010.
6. “Semaglutide for Weight Loss: Risks, Side Effects and More.” Forbes Health, 1 Aug. 2023. https://www.forbes.com/health/weight-loss/semaglutide/